GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senseonics Holdings Inc (AMEX:SENS) » Definitions » ROE %

Senseonics Holdings (Senseonics Holdings) ROE % : -156.52% (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Senseonics Holdings ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Senseonics Holdings's annualized net income for the quarter that ended in Dec. 2023 was $-68.76 Mil. Senseonics Holdings's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $43.93 Mil. Therefore, Senseonics Holdings's annualized ROE % for the quarter that ended in Dec. 2023 was -156.52%.

The historical rank and industry rank for Senseonics Holdings's ROE % or its related term are showing as below:

SENS' s ROE % Range Over the Past 10 Years
Min: -4945.69   Med: -363.59   Max: Negative Equity
Current: -149.27

During the past 10 years, Senseonics Holdings's highest ROE % was Negative Equity%. The lowest was -4,945.69%. And the median was -363.59%.

SENS's ROE % is ranked worse than
91.25% of 811 companies
in the Medical Devices & Instruments industry
Industry Median: 0.13 vs SENS: -149.27

Senseonics Holdings ROE % Historical Data

The historical data trend for Senseonics Holdings's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senseonics Holdings ROE % Chart

Senseonics Holdings Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -369.10 - - Negative Equity -363.59

Senseonics Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Negative Equity 17.11 -139.64 -184.34 -156.52

Competitive Comparison of Senseonics Holdings's ROE %

For the Medical Devices subindustry, Senseonics Holdings's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Senseonics Holdings's ROE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Senseonics Holdings's ROE % distribution charts can be found below:

* The bar in red indicates where Senseonics Holdings's ROE % falls into.



Senseonics Holdings ROE % Calculation

Senseonics Holdings's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-60.392/( (-2.576+35.796)/ 2 )
=-60.392/16.61
=-363.59 %

Senseonics Holdings's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-68.76/( (52.065+35.796)/ 2 )
=-68.76/43.9305
=-156.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Senseonics Holdings  (AMEX:SENS) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-68.76/43.9305
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-68.76 / 32.12)*(32.12 / 146.1425)*(146.1425 / 43.9305)
=Net Margin %*Asset Turnover*Equity Multiplier
=-214.07 %*0.2198*3.3267
=ROA %*Equity Multiplier
=-47.05 %*3.3267
=-156.52 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-68.76/43.9305
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-68.76 / -68.76) * (-68.76 / -68.016) * (-68.016 / 32.12) * (32.12 / 146.1425) * (146.1425 / 43.9305)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * 1.0109 * -211.76 % * 0.2198 * 3.3267
=-156.52 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Senseonics Holdings ROE % Related Terms

Thank you for viewing the detailed overview of Senseonics Holdings's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Senseonics Holdings (Senseonics Holdings) Business Description

Traded in Other Exchanges
Address
20451 Seneca Meadows Parkway, Germantown, MD, USA, 20876-7005
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of the glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.
Executives
Sharon Larkin director C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Douglas A Roeder director 160 BOVET RD, SUITE 408, C/O DELPHI VENTURES, SAN MATEO CA 94402
Frederick T. Sullivan officer: Chief Financial Officer C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Mukul Jain officer: VP Operations, Qual & Reg 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Edward Fiorentino director 1350 KENNICOTT DRIVE, LAKE FOREST IL 60045
Mirasol Panlilio officer: VP Global Sales & Marketing 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Timothy T Goodnow director, officer: President & Chief Exec Officer 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Francine Kaufman officer: Chief Medical Officer C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Kenneth L Horton officer: GC & Corp. Development Advisor VERTEX PHARMACEUTICALS INCORPORATED, 130 WAVERLY STREET, CAMBRIDGE MA 02139
Nick B. Tressler officer: Chief Financial Officer C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 208786
Anthony R. Raab director C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
John Marotta director C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Stephen P Defalco director ONE EXETER STREET, BOSTON MA 02116
Douglas S Prince director 20 TILESTON STREET, PH4, BOSTON MA 02113
Edelman Steven director C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876

Senseonics Holdings (Senseonics Holdings) Headlines

From GuruFocus